FDA Press Releases
FDA Press Releases
The feed below is an automatic RSS feed from the FDA website.
- FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk
- FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma
- FDA Provides Clarity to Support Cell and Gene Therapy Development and Quality
- FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis
- FDA Launches New Program to Advance Neuroscience Medical Product Development
- FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
- FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
- FDA Issues Final Guidance on Prescription Drug Apps and Software
- FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery
- FDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug Development
- FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
- FDA Seeks Public Input to Support Ibogaine Research
- FDA Approves First Heart Valve Designed to Grow with Children
- FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees
- FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme